Thank you to our Foundational and Sustaining members
Bio-Techne will open $40M+ facility in St. Paul IBM, Mayo Clinic, Geisinger among 25 finalists for $1.6M CMS artificial intelligence challenge Medtronic wins FDA breakthrough nod for fully implantable LVAD Minnesota Startups Raised $70.8M in Q3 Boston Sci Gives Update on the Measured Launch of Lotus Edge Meet The Most Disruptive MBA Startups Of 2019 […]
Phase 2 Results: Microbiota-Based RBX2660 Safe, Efficacious for Preventing C diff Recurrence Medtronic Bids for FDA Approval of OAB/FI Neuromodulation Device – MassDevice Recombinetics Announces Collaboration with Mayo Clinic to Develop the First-Ever Swine Models of Osteogenesis Imperfecta This Is the Strongest Pipeline in Medtronic’s History Funding Roundup: 4C Medical Spineology Seek Millions West Monroe […]
MINNEAPOLIS, Oct. 10, 2019/PRNewswire/ – Bio-Techne Corporation (NASDAQ:TECH) today announced that the Medicare Administrative Contractor (MAC) National Government Services, Inc. issued a final Local Coverage Decision (LCD) covering the ExoDx Prostate(IntelliScore) – EPI – test for men who are being considered for an initial prostate biopsy. The decision is effective for tests administered on or […]
MINNEAPOLIS, Oct. 7, 2019/PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH), a family of brands with a unique and leading portfolio of reagents and instruments for life science and clinical research, has been validating a growing number of immunohistochemistry (IHC) antibodies using the Advanced Cell Diagnostics-branded RNAscope in situ hybridization (ISH) platform to leverage its transcriptomics approach […]
MAA Congratulates Jodi Hubler on Her Appointment to Launch Minnesota Advisory Board CEOs of Minnesota’s biggest health players take aim AI myths Senate lawmakers direct CMS to boost non-opioid device reimbursement UEL Joins BARDA Accelerator Network University of Minnesota discovery is now a first-in-human clinical trial for leukemia 3M and M*Modal Combine Advanced Technologies to […]
MINNEAPOLIS, Sept. 16, 2019/PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced that it has attained ISO 9001:2015 certification at its fetal bovine serum (FBS) and specialty media manufacturing facility in Flowery Branch, Georgia. ISO 9001:2015 is an international Business Quality Management System standard that is recognized globally as an indicator of quality excellence. This certification […]
Blue Cross and Blue Shield of Minnesota to drop insulin co-pay to $0 CVRx Receives FDA Approval for World’s First Heart Failure Neuromodulation Device Q&A: ‘The key is going to be providing information that’s actually helpful’ U.S. health care system must adopt nimbler, more transparent model Starkey Hearing Technologies Named Stevie Awards Winner New cancer […]
MINNEAPOLIS, August 20, 2019/PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced the release of the Maurice Empower® Control Kit for the ProteinSimpleTM- branded Maurice platform. This new kit enables users to collect, manage and report Maurice results with the industry leading Empower® 3 Software from WatersTM Corporation. Since its introduction in 2016, the Maurice platform […]
Fairview acquires Wisconsin-based Vibrant Health AtriCure offers $300m for SentreHeart Bio-Techne: $50m reagent plant support cell & genes Mayo Clinic invests in breast cancer imaging AI We’re Starting to Harness the Microbiome to Treat Disease Despite a Cold M&A Market in Minnesota, Deal Activity in Healthcare Remains Hot UK regulators OK Boston Scientific’s $4B BTG […]
MINNEAPOLIS and SOUTHPORT, August 13, 2019/PRNewswire/ — Bio-Techne Corporation and Cygnus Technologies, part of Maravai LifeSciences, announced today a strategic partnership for the quantification of Chinese hamster ovary host cell proteins (CHO-HCP) on the ProteinSimpleTM-branded EllaTM immunoassay platform. Under the terms of the agreement, Bio-Techne and Cygnus are introducing the co-developed third generation CHO-HCP assay […]